Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation
Open Access
- 10 November 2006
- journal article
- Published by Elsevier BV
- Vol. 281 (45), 34374-34380
- https://doi.org/10.1074/jbc.m607325200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary glandDevelopment, 2003
- The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signalingTrends in Biochemical Sciences, 2003
- SHP-2 Is a Dual-specificity Phosphatase Involved in Stat1 Dephosphorylation at Both Tyrosine and Serine Residues in NucleiPublished by Elsevier BV ,2002
- Prolactin Induces SHP-2 Association with Stat5, Nuclear Translocation, and Binding to the β-Casein Gene Promoter in Mammary CellsPublished by Elsevier BV ,2002
- Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epitheliumThe Journal of cell biology, 2001
- SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor–deficient miceGenes & Development, 2001
- Shp-2 has a positive regulatory role in ES cell differentiation and proliferationOncogene, 1998
- Dominant Negative Variants of the SHP-2 Tyrosine Phosphatase Inhibit Prolactin Activation of Jak2 (Janus Kinase 2) and Induction of Stat5 (Signal Transducer and Activator of Transcription 5)-Dependent TranscriptionMolecular Endocrinology, 1998
- Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiationMolecular Endocrinology, 1996
- Differential activation of STATs 3 and 5 during mammary gland developmentFEBS Letters, 1996